Craniosynostosis is a condition characterized by premature fusion of the cranial suture(s). In 80% of the cases premature fusion affects only one suture, it is also known as isolated craniosynostosis. Those children are otherwise healthy, without any comorbidity. In 20% of the cases, craniosynostosis is associated with abnormalities like Crouzon, Apert, Pfeiffer, or other syndromes, and their consequences. Elevated intracranial pressure and hydrocephalus are more frequent in the case of syndromic craniosynostosis [
15]. Timing of elective surgery is controversial but usually performed at 3–6 months of age. In this period of life, the bones are soft and easy to reshape. If the surgery is done later, between 6 and 12 months of age, increased blood volume is an advantage with less transfusion need. In the case of syndromic craniosynostosis, cardiac status has to be evaluated [
16]. Surgical techniques can vary from strip craniectomy to total vault remodeling. Reduced temporomandibular joint movement, fused cervical spines, or facial abnormalities may lead to difficult airway management. Obstructive sleep apnea (OSA) may occur in 50% of multisutural and syndromic cases leading to difficult intubation and extubation. Anesthesia induction with volatile agents has the advantage to minimize the risk of sudden airway loss. Patients are frequently operated on in prone position or modified prone position or supine position. The main risks are intraoperative hypothermia, massive bleeding requiring transfusion, and venous air embolism (VAE). Low core temperature can lead to coagulopathy, requiring massive transfusion. It is challenging to estimate the exact blood loss because most of the wasted blood goes to the surgical drapes and surrounding area. A recent study showed that early fibrinogen replacement according to fibrin-based thromboelastometry control significantly decreases the transfusion need in the settings of craniosynostosis surgery [
17]. According to this data, fibrinogen level control before the surgery is advocated. Tranexamic acid (TXA) is frequently used to decrease intraoperative blood loss during pediatric neurosurgery. Very recent studies established the exact dose of TXA in the case of craniosynostosis surgery. These studies showed that the loading dose of 10 mg/kg, followed by 5–10 mg/kg/h, may reduce the transfusion need by two-thirds without any side effects [
18••]. The incidence of VAE varies according to the literature and may be up to 82% in the case of craniosynostosis surgery. In the case of pediatric neurosurgery, it may remain without clinical signs, but a precordial Doppler and sudden drop of end tidal carbon dioxide may help to diagnose it. The neurosurgeon has to be informed immediately when VAE is assumed [
19]. In infants, assessing pain is challenging, and pain management is an underestimated problem. A scalp nerve block with 0.25% levobupivacaine (1 ml/kg) and epinephrine can reduce the postoperative pain mainly in the first 24 h. The use of nonsteroidal antiinflammatory drugs (NSAIDs) is controversial, as they can facilitate postoperative bleeding. Oversedation with high-dose opioids should be avoided especially in the case of OSA [
20].